{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:36:33Z","timestamp":1790181393440,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s10875-014-0038-z","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T04:15:12Z","timestamp":1398226512000},"page":"594-599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Elevated Double Negative T Cells in Pediatric Autoimmunity"],"prefix":"10.1007","volume":"34","author":[{"given":"James A.","family":"Tarbox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly P.","family":"Keppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermina","family":"Topcagic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mackin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ben Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W.","family":"Baszis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"38_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/IR:23:2-3:235","volume":"23","author":"JW Thomas","year":"2001","unstructured":"Thomas JW. Antigen-specific responses in autoimmunity and tolerance. Immunol Res. 2001;23:235\u201344.","journal-title":"Immunol Res"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.4049\/jimmunol.165.9.5338","volume":"165","author":"PA Sieling","year":"2000","unstructured":"Sieling PA, Porcelli SA, Duong BT, Spada F, Bloom BR, Diamond B, et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol. 2000;165:5338\u201344.","journal-title":"J Immunol"},{"key":"38_CR3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/ACI.0b013e3283588da0","volume":"12","author":"TA Fleisher","year":"2012","unstructured":"Fleisher TA, Oliveira JB. Monogenic defects in lymphocyte apoptosis. Curr Opin Allergy Clin Immunol. 2012;12:609\u201315.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/1529-0131(199909)42:9<1833::AID-ANR7>3.0.CO;2-Q","volume":"42","author":"AK Vaishnaw","year":"1999","unstructured":"Vaishnaw AK, Toubi E, Ohsako S, Drappa J, Buys S, Estrada J, et al. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas\/APO-1) mutations. Arthritis Rheum. 1999;42:1833\u201342.","journal-title":"Arthritis Rheum"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","volume":"116","author":"JB Oliveira","year":"2010","unstructured":"Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116:e35\u201340.","journal-title":"Blood"},{"key":"38_CR6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.autrev.2010.02.007","volume":"9","author":"JC Turbyville","year":"2010","unstructured":"Turbyville JC, Rao VK. The autoimmune lymphoproliferative syndrome: a rare disorder providing clues about normal tolerance. Autoimmun Rev. 2010;9:488\u201393.","journal-title":"Autoimmun Rev"},{"key":"38_CR7","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2010-01-263145","volume":"115","author":"KC Dowdell","year":"2010","unstructured":"Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, et al. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood. 2010;115:5164\u20139.","journal-title":"Blood"},{"key":"38_CR8","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa040036","volume":"351","author":"E Holzelova","year":"2004","unstructured":"Holzelova E, Vonarbourg C, Stolzenberg M-C, Arkwright PD, Selz F, Prieur A-M, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409\u201318.","journal-title":"N Engl J Med"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crisp\u00edn","year":"2008","unstructured":"Crisp\u00edn JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181:8761\u20136.","journal-title":"J Immunol"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4049\/jimmunol.143.1.103","volume":"143","author":"S Shivakumar","year":"1989","unstructured":"Shivakumar S, Tsokos GC, Datta SK. T cell receptor alpha\/beta expressing double-negative (CD4-\/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol. 1989;143:103\u201312.","journal-title":"J Immunol"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1191\/0961203302lu235oa","volume":"11","author":"A Anand","year":"2002","unstructured":"Anand A, Dean G, Quereshi K, Isenberg D, Lydyard P. Characterization of CD3 + CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers. Lupus. 2002;11:493\u2013500.","journal-title":"Lupus"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/eji.201040982","volume":"41","author":"S Voelkl","year":"2011","unstructured":"Voelkl S, Gary R, Mackensen A. Characterization of the immunoregulatory function of human TCR-\u03b1\u03b2 + CD4\u2013CD8- double-negative T cells. Eur J Immunol. 2011;41:739\u201348.","journal-title":"Eur J Immunol"},{"key":"38_CR13","unstructured":"Hillhouse EE, Lesage S. A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells. J Autoimmun. 2012;1\u20138."},{"key":"38_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jmcb\/mjr043","volume":"4","author":"SC Juvet","year":"2012","unstructured":"Juvet SC, Zhang L. Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions. J Mol Cell Biol. 2012;4:48\u201358.","journal-title":"J Mol Cell Biol"},{"key":"38_CR15","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"M Hochberg","year":"1997","unstructured":"Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"38_CR16","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1182\/blood-2009-08-239525","volume":"115","author":"AE Seif","year":"2010","unstructured":"Seif AE, Manno CS, Sheen C, Grupp SA, Teachey DT. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood. 2010;115:2142\u20135.","journal-title":"Blood"},{"key":"38_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mcp.2005.05.004","volume":"20","author":"JE Niemela","year":"2006","unstructured":"Niemela JE, Hsu AP, Fleisher TA, Puck JM. Single nucleotide polymorphisms in the apoptosis receptor gene TNFRSF6. Mol Cell Probes. 2006;20:21\u20136.","journal-title":"Mol Cell Probes"},{"key":"38_CR19","first-page":"192","volume":"309","author":"V Appay","year":"2006","unstructured":"Appay V, Reynard S, Voelter V, Romero P, Speiser DE, Leyvraz S. Immuno-monitoring of CD8+ T cells in whole blood versus PBMC samples. J Clin Immunol. 2006;309:192\u20139.","journal-title":"J Clin Immunol"},{"key":"38_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2009.07991.x","volume":"148","author":"DT Teachey","year":"2009","unstructured":"Teachey DT, Seif AE, Grupp SA. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Brit J Haematol. 2009;148:205\u201316.","journal-title":"Brit J Haematol"},{"key":"38_CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/clim.2002.5225","volume":"104","author":"JJ Bleesing","year":"2002","unstructured":"Bleesing JJ, Brown MR, Novicio C, Guarraia D, Dale JK, Straus SE, et al. A composite picture of TcR\u03b1\/\u03b2 + CD4-CD8- T Cells (\u03b1\/\u03b2-DNTCs) in humans with Autoimmune Lymphoproliferative Syndrome. Clin Immunol. 2002;104:21\u201330.","journal-title":"Clin Immunol"},{"key":"38_CR22","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, et al. A human memory T cell subset with stem cell-like properties. Nat Med. 2011;17:1290\u20137.","journal-title":"Nat Med"},{"key":"38_CR23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.coi.2012.04.001","volume":"24","author":"SM Henson","year":"2012","unstructured":"Henson SM, Riddell NE, Akbar AN. Properties of end-stage human T cells defined by CD45RA re-expression. Curr Opin Immunol. 2012;24:476\u201381.","journal-title":"Curr Opin Immunol"},{"key":"38_CR24","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4049\/jimmunol.161.4.1686","volume":"161","author":"WZ Mehal","year":"1998","unstructured":"Mehal WZ, Crispe IN. TCR ligation on CD8+ T cells creates double-negative cells in vivo. J Immunol. 1998;161:1686\u201393.","journal-title":"J Immunol"},{"key":"38_CR25","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.4049\/jimmunol.0901533","volume":"183","author":"JC Crisp\u00edn","year":"2009","unstructured":"Crisp\u00edn JC, Tsokos GC. Human TCR-alpha beta + CD4\u2013CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype. J Immunol. 2009;183:4675\u201381.","journal-title":"J Immunol"},{"key":"38_CR26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.immuni.2012.08.014","volume":"37","author":"P Pisitkun","year":"2012","unstructured":"Pisitkun P, Ha H-L, Wang H, Claudio E, Tivy CC, Zhou H, et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity. 2012;37:1104\u201315.","journal-title":"Immunity"},{"key":"38_CR27","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood-2004-07-2583","volume":"105","author":"K Fischer","year":"2005","unstructured":"Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, Laumer M, et al. Isolation and characterization of human antigen-specific TCR alpha beta + CD4 (\u2212) CD8-double-negative regulatory T cells. Blood. 2005;105:2828\u201335.","journal-title":"Blood"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-014-0038-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0038-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T09:53:40Z","timestamp":1689155620000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-014-0038-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s10875-014-0038-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}